Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Minimally Invasive Surgery in Treating Patients With Spinal Tumors

3. juni 2015 opdateret af: City of Hope Medical Center

Comparison of Minimally Invasive Approaches of Spine Tumor Surgery

This randomized clinical trial studies minimally invasive surgery in treating patients with spinal tumors. Posterior spinal tumor resection and anterior and posterior spinal tumor resection are less invasive types of surgery for spinal tumors and may have fewer side effects and improve recovery

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

PRIMARY OBJECTIVES:

I. Length of operation (operating room [OR] time). II. Estimated blood loss (EBL). III. Complication rate. IV. Neurological preservation.

SECONDARY OBJECTIVES:

I. Motor strength and sensory level (neurological outcome). II. Bladder and bowel function. III. Post-operative pain. IV. Hospital length of stay (recovery time). V. Arthrodesis.

OUTLINE: Patients are randomized to 1 of 2 treatment arms.

ARM I: Patients undergo posterior spinal tumor resection on day 0.

ARM II: Patients undergo anterior and posterior spinal tumor resection on day 0.

After completion of study treatment, patients are followed up for 6 months.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

7

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

  • Forenede Stater
    • California
      • Duarte, California, Forenede Stater, 91010
        • City of Hope Medical Center

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Patients must have a diagnosis of primary, secondary or metastatic spine tumor and be undergoing any posterior spinal fusion with or without anterior fusion anywhere from occiput to sacrum
  • Greater than 3 month life expectancy
  • Women of child-bearing potential must agree to use adequate contraception (hormonal or barrier method of birth control or abstinence) prior to study entry and for six months following duration of study participation; should a woman become pregnant or suspect that she is pregnant while participating on the trial, she should inform her treating physician immediately
  • All subjects must have the ability to understand and the willingness to sign a written informed consent

Exclusion Criteria:

  • Patients who are not surgical candidates for spine tumor removal, determined by the surgical team
  • Patients who have undergone previous spine surgery for tumor removal will be excluded
  • Patients with renal cell carcinoma
  • As there is an emphasis on blood loss and length of surgery, the critical variable for homogeneity is the vascularity of the tumor; hypervascular spine tumors are regarded by surgeons as amongst the most challenging of cases; by far the three most common hypervascular metastatic tumors are those arising from renal cell carcinoma, thyroid carcinoma and melanoma; these pathologies are usually regarded as a distinct subset for this reason in the majority of studies; because we rarely encounter the later two pathologies in our practice, we chose to include only the former; however, to further homogenize our study population we will exclude all three of the known hypervascular metastatic spine tumors
  • Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Arm I (posterior spinal tumor resection)
Patients undergo posterior spinal tumor resection on day 0.
Procedure: livskvalitetsvurdering
Hjælpestudier
Andre navne:
  • livskvalitetsvurdering
Procedure: therapeutic conventional surgery
Undergo posterior spinal tumor resection
Procedure: therapeutic conventional surgery
Undergo anterior and posterior spinal tumor resection
Eksperimentel: Arm II (anterior and posterior spinal tumor resection)
Patients undergo anterior and posterior tumor resection on day 0.
Procedure: livskvalitetsvurdering
Hjælpestudier
Andre navne:
  • livskvalitetsvurdering
Procedure: therapeutic conventional surgery
Undergo posterior spinal tumor resection
Procedure: therapeutic conventional surgery
Undergo anterior and posterior spinal tumor resection

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Estimated blood loss (EBL); in milliliters (ml)
Tidsramme: Day 0
Will be comparing means with the Wilcoxon test.
Day 0
Length of operation (OR time)
Tidsramme: Day 0
Will be comparing means with the Wilcoxon test.
Day 0
Complication rate
Tidsramme: Day 0
Day 0
Neurological preservation
Tidsramme: Post operation day 90
Post operation day 90

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Length of stay
Tidsramme: Less than 7 days
Less than 7 days
Pain symptoms
Tidsramme: Pre-operation, post-op day 3, discharge, post-op days 7, 28, 60, and 90
Pre-operation, post-op day 3, discharge, post-op days 7, 28, 60, and 90
Assessment of neurologic function using the ASIA (American Spinal Injury Association) Impairment Scale
Tidsramme: Pre-operation, post-op day 3, discharge, post-op days 7, 28, 60, and 90
This is an assessment of sensory and motor functions based upon the ASIA Impairment Scale
Pre-operation, post-op day 3, discharge, post-op days 7, 28, 60, and 90
Evaluation of arthrodesis
Tidsramme: Post-op day 1, 28, and 90
Plain x-ray films and CT scans are used to determine the success of arthrodesis (spinal fusion in this case) which is the artificial induction of joint ossification between two bones via surgery. This is done to relieve intractable pain in a joint which cannot be managed by pain medication.
Post-op day 1, 28, and 90

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

City of Hope Medical Center

Samarbejdspartnere

National Cancer Institute (NCI)

Efterforskere

  • Ledende efterforsker: Rahul Jandial, MD, City of Hope Medical Center

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. maj 2012

Primær færdiggørelse (Faktiske)

1. juni 2014

Studieafslutning (Faktiske)

1. juni 2014

Datoer for studieregistrering

Først indsendt

1. marts 2011

Først indsendt, der opfyldte QC-kriterier

2. marts 2011

Først opslået (Skøn)

4. marts 2011

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

8. juni 2015

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

3. juni 2015

Sidst verificeret

1. juni 2015

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • 10115 (DAIDS-ES)
  • NCI-2011-00231 (Registry Identifier: CTRP (Clinical Trial Reporting Program))

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Voksen rygmarvsneoplasma

Kliniske forsøg med livskvalitetsvurdering

Søg i lignende forsøg

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

CROs by country

CROs in Brazil

Betingelser

Sjældne sygdomme

Narkotikainterventioner

Kosttilskud

Sponsor / samarbejdspartnere

Placeringer

Abonner